Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

medRxiv(2021)10.1101/2021.03.31.21254660Source: DataRank Database

Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants is a research paper published in medRxiv (2021). On theSindex it has a DataRank of 0.524. It has been cited 32 times.

N/A

0.524DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

gen uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (39)IDs (PubMed, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.524

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (12)

Mohammed Nure Alam Siddiquey ORCID,Chuan-Tien Hung ORCID,Griffin D. Haas ORCID,Luca Brambilla ORCID,Kasopefoluwa Y. Oguntuyo ORCID

Live enrichment

PubMed:33821288 OpenAlex:https://openalex.org/W3146830078

National Institutes of Health

Grant: 5F31AI154739-02

Elucidating the molecular determinants of Henipavirus envelope-antibody and envelope-receptor interactions on viral entry

National Institutes of Health

Grant: 5R01AI138921-04

Efficient Sendai virus mediated CRISPR/Cas9 gene editing to protect hematopoietic stem cells from HIV

National Institutes of Health

Grant: 5R01AI123449-02

Tropism, pathogenicity, and potential for zoonotic spillover of emergent henipa- and henipa-like viruses

National Institutes of Health

Grant: 5T32AI007647-15

TRAINING PROGRAM IN MECHANISMS OF VIRUS-HOST INTERACTIONS

NIAID NIH HHS

Grant: F31 AI154739

NIAID NIH HHS

Grant: R01 AI123449

NIAID NIH HHS

Grant: R01 AI138921

NIAID NIH HHS

Grant: T32 AI007647

greenLicense: cc-by-nc-nd

repositoryhttps://www.medrxiv.org/content/medrxiv/early/2021/05/29/2021.03.31.21254660.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2021.03.31.21254660

repositoryhttps://doi.org/10.1101/2021.03.31.21254660

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33821288

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies

Keywords

VirologyVesicular stomatitis virusBiologyPandemicOutbreakPorcine epidemic diarrhea virusCoronavirusHerd immunityVirusAntibodyImmunityVaccinationImmunologyImmune systemCoronavirus disease 2019 (COVID-19)MedicineInfectious disease (medical specialty)Coronavirus Disease 2019 ResearchFOS: Health sciencesGeneArticleCoronavirus Disease 2019Agricultural and Biological SciencesHealth SciencesGeneticsPathologyDiseaseViral Diseases in Livestock and PoultryVaccinesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)FOS: Clinical medicineHEK 293 cellsLife SciencesInfectious DiseasesFOS: Biological sciencesAnimal Science and Zoology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being